Donna Ambrosino
Director/Board Member at CLOVER BIOPHARMACEUTICALS, LTD.
Net worth: 6 925 $ as of 29/04/2024
Profile
Donna M.
Ambrosino is a professional with a doctorate degree from Dartmouth Medical School and an undergraduate degree from Harvard University.
She is currently a Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2022.
Previously, she worked as the Chief Medical Officer at Visterra, Inc. from 2012 to 2014.
She also held the position of Associate Professor at Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/04/2024 | 156,992 ( 0.01% ) | 6 925 $ | 29/04/2024 |
Donna Ambrosino active positions
| Companies | Position | Start |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 16/06/2022 |
Former positions of Donna Ambrosino
| Companies | Position | End |
|---|---|---|
| VISTERRA INC | Chief Tech/Sci/R&D Officer | 31/12/2013 |
| Harvard Medical School | Corporate Officer/Principal | - |
Training of Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Donna Ambrosino
